tiprankstipranks
Biofrontera AG (GB:0DOL)
LSE:0DOL

Biofrontera (0DOL) Financial Statements

0 Followers

Biofrontera Financial Overview

Biofrontera's market cap is currently ―. The company's EPS TTM is €-0.005; its P/E ratio is -202.07; Biofrontera is scheduled to report earnings on May 29, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Mar 23Sep 22Sep 21
Income Statement-
Total Revenue€ 10.59M€ 8.90M€ 8.73M€ 6.83M€ 5.38M
Gross Profit€ 5.66M€ 4.33M€ 4.16M€ 5.74M€ 4.68M
EBIT-€ -6.20M€ -7.44M€ -4.59M€ -4.75M
EBITDA-€ -6.20M€ -7.18M€ -4.59M€ -4.75M
Net Income Common Stockholders€ 3.53M€ -6.34M€ -7.48M€ -5.10M€ -5.73M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 1.34M€ 3.42M€ 21.10M€ 1.61M€ 30.91M
Total Assets€ 27.93M€ 34.10M€ 41.97M€ 29.04M€ 69.23M
Total Debt€ 5.40M€ 2.81M€ 1.21M€ 3.28M€ 24.62M
Net Debt€ 4.06M€ -608.00K€ -19.89M€ 1.66M€ -6.29M
Total Liabilities€ 23.14M€ 33.07M€ 25.21M€ 12.85M€ 53.33M
Stockholders Equity€ 4.79M€ 1.04M€ 16.75M€ 16.19M€ 15.89M
Cash Flow-
Free Cash Flow--€ -3.71M--
Operating Cash Flow€ -8.90M€ -2.00M€ -3.70M--
Investing Cash Flow€ 73.00K€ 382.00K€ -14.00K--
Financing Cash Flow€ 6.71M€ 591.00K---
Currency in EUR

Biofrontera Earnings and Revenue History

Biofrontera Debt to Assets

Biofrontera Cash Flow

Biofrontera Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis